In IL-6−/− mice fed HFD, the hepatic expression of CPT1 and AMPK activity remained at basal levels, which likely promote a deficit in the fatty acid oxidation process, thereby contributing to the steatosis aggravation in IL-6−/− mice. Here, CPT1A is linked to steatosis.